6 January 2005
New findings from a study by the National Institute for Occupational Safety and Health (NIOSH) and the Pacific Health Research Institute provide further evidence that a protein in the human brain, glial fibrillary acidic protein (GFAP), can serve as a valuable mark
27 December 2004
(Jackonsville, FL) - Researchers at Mayo Clinic in Jacksonville, Fla., have developed a way to create human brain cells in culture that model a key pathology of Alzheimer's disease (AD) and related disorders.
1 November 2004
University of Kentucky chemistry professor Allan Butterfield has uncovered new clues about how brain cells are damaged by Alzheimer's disease, evidence suggesting vitamin E may help prevent the debilitating illness.
28 October 2004
In conjunction with the Institute for the Study of Aging (ISOA), IOS Press is pleased to announce the forthcoming publication of the Proceedings of an ISOA Catalyst Conference as a special print and online Supplement to the December 2004 issue of the Journal of Al
27 October 2004
Inhibiting Apolipoprotein E Possible Means of Therapeutic Intervention for Alzheimer’s Disease
25 October 2004
Alzheimer's disease is characterized by progressive loss of cognitive function due to amyloid-beta (Aß) deposits in the central nervous system. If these deposits could be stopped or slowed, Alzheimer's disease might become more manageable.
23 August 2004
Pilot study shows that selectively draining isoprostanes from cerebrospinal fluid stabilizes cognitive decline
23 August 2004
Tangled strands of proteins called amyloid are found in the brain tissues of patients with a variety of neurodegenerative disorders such as Alzheimer's disease and Parkinson's disease.
5 August 2004
In recognition of outstanding work published in the Journal of Alzheimer's Disease
21 June 2004
Alzheimer's disease patients often have seemingly unrelated abnormalities in their brain cells.